Terms: = Colorectal cancer AND TOP2A, TOP2, TP2A
43 results:
1. Identification of potential key genes for colorectal cancer based on bioinformatics analysis.
Li C; Cao S; Guo M; Guo A; Sun X
Medicine (Baltimore); 2023 Dec; 102(51):e36615. PubMed ID: 38134110
[TBL] [Abstract] [Full Text] [Related]
2. Research on radiotherapy related genes and prognostic target identification of rectal cancer based on multi-omics.
Liu Y; Yang Y; Ni F; Tai G; Yu C; Jiang X; Wang D
J Transl Med; 2023 Nov; 21(1):856. PubMed ID: 38012642
[TBL] [Abstract] [Full Text] [Related]
3. Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities.
Nayan SI; Rahman MH; Hasan MM; Raj SMRH; Almoyad MAA; Liò P; Moni MA
Life Sci; 2023 Dec; 335():122244. PubMed ID: 37949208
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
[TBL] [Abstract] [Full Text] [Related]
5. [Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy].
Iranzo P; Callejo A; Arbej J; Menao S; Isla D; Andrés R
An Sist Sanit Navar; 2023 Aug; 46(2):. PubMed ID: 37594060
[TBL] [Abstract] [Full Text] [Related]
6. Network pharmacology and metabolomics elucidate the underlying mechanisms of Venenum Bufonis in the treatment of colorectal cancer.
Tao C; Wang J; Gu Z; Ni H; Luo Y; Ling J; Chen Y; Wu Y; Liu X; Zhou Y; Xu T
J Ethnopharmacol; 2023 Dec; 317():116695. PubMed ID: 37315651
[TBL] [Abstract] [Full Text] [Related]
7. Chalcone Derivative CX258 Suppresses colorectal cancer via Inhibiting the top2a/Wnt/β-Catenin Signaling.
Chen X; Lv X; Gao L; Liu J; Wang W; Guo L; Frasinyuk MS; Zhang W; Watt DS; Liu C; Liu X
Cells; 2023 Mar; 12(7):. PubMed ID: 37048139
[TBL] [Abstract] [Full Text] [Related]
8. Transcriptomic Signatures in colorectal cancer Progression.
Ershov P; Poyarkov S; Konstantinova Y; Veselovsky E; Makarova A
Curr Mol Med; 2023; 23(3):239-249. PubMed ID: 35490318
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract] [Full Text] [Related]
10. [Screening of differentially expressed genes for colorectal cancer and prediction of potential traditional Chinese medicine: based on bioinformatics].
Yun ZJ; Wang HJ; Yu YX; Sun ZY; Yao SK
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(6):1666-1676. PubMed ID: 35347966
[TBL] [Abstract] [Full Text] [Related]
11. Smell Detection Agent Optimisation Framework and Systems Biology Approach to Detect Dys-Regulated Subnetwork in cancer Data.
Sivan SL; Sukumara Pillai VCS
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053185
[TBL] [Abstract] [Full Text] [Related]
12. Identification of potential core genes in colorectal carcinoma and key genes in colorectal cancer liver metastasis using bioinformatics analysis.
Niu L; Gao C; Li Y
Sci Rep; 2021 Dec; 11(1):23938. PubMed ID: 34907282
[TBL] [Abstract] [Full Text] [Related]
13.
Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
[TBL] [Abstract] [Full Text] [Related]
14. UPF1 promotes chemoresistance to oxaliplatin through regulation of top2a activity and maintenance of stemness in colorectal cancer.
Zhu C; Zhang L; Zhao S; Dai W; Xu Y; Zhang Y; Zheng H; Sheng W; Xu Y
Cell Death Dis; 2021 May; 12(6):519. PubMed ID: 34021129
[TBL] [Abstract] [Full Text] [Related]
15. Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Jia Z; Zhang Z; Tian Q; Wu H; Xie Y; Li A; Zhang H; Yang Z; Zhang X
Gene; 2021 Jun; 786():145625. PubMed ID: 33798683
[TBL] [Abstract] [Full Text] [Related]
16. A data-driven approach to a chemotherapy recommendation model based on deep learning for patients with colorectal cancer in Korea.
Park JH; Baek JH; Sym SJ; Lee KY; Lee Y
BMC Med Inform Decis Mak; 2020 Sep; 20(1):241. PubMed ID: 32962726
[TBL] [Abstract] [Full Text] [Related]
17. The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and top2.
Marzi L; Sun Y; Huang SN; James A; Difilippantonio S; Pommier Y
Mol Cancer Ther; 2020 Aug; 19(8):1589-1597. PubMed ID: 32430490
[TBL] [Abstract] [Full Text] [Related]
18. Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for colorectal cancer.
Abraham AD; Esquer H; Zhou Q; Tomlinson N; Hamill BD; Abbott JM; Li L; Pike LA; Rinaldetti S; Ramirez DA; Lunghofer PJ; Gomez JD; Schaack J; Nemkov T; D'Alessandro A; Hansen KC; Gustafson DL; Messersmith WA; LaBarbera DV
J Med Chem; 2019 Nov; 62(22):10182-10203. PubMed ID: 31675229
[TBL] [Abstract] [Full Text] [Related]
19. Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer.
Serna G; Ruiz-Pace F; Cecchi F; Fasani R; Jimenez J; Thyparambil S; Landolfi S; Elez E; Vivancos A; Hembrough T; Tabernero J; Dienstmann R; Nuciforo P
Sci Rep; 2019 Sep; 9(1):13568. PubMed ID: 31537838
[TBL] [Abstract] [Full Text] [Related]
20. Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas.
Murugesan SN; Yadav BS; Maurya PK; Chaudhary A; Singh S; Mani A
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180040
[TBL] [Abstract] [Full Text] [Related]
[Next]
